Rudakova, A. V., Meshkov, D. O., & Mishugin, S. V. (2014). Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy. ABV-press.
Chicago Style citaatRudakova, A. V., D. O. Meshkov, en S. V. Mishugin. Cost-effectiveness of Abiraterone Treatment in Patients With Castration-resistant Prostate Cancer Who Previously Received Docetaxel Therapy. ABV-press, 2014.
MLA citatieRudakova, A. V., D. O. Meshkov, en S. V. Mishugin. Cost-effectiveness of Abiraterone Treatment in Patients With Castration-resistant Prostate Cancer Who Previously Received Docetaxel Therapy. ABV-press, 2014.
Let op: Deze citaties zijn niet altijd 100% accuraat.